(Q46693462)

24 December 2017

title

Lipoprotein [a] is cleared from the plasma primarily by the liver in a process mediated by apolipoprotein [a]. (English)

1 reference

24 December 2017

0 references

1 reference

William J Cain

1

1 reference

24 December 2017

John S Millar

2

1 reference

24 December 2017

Adam S Himebauch

3

1 reference

24 December 2017

Uwe J F Tietge

4

1 reference

24 December 2017

Cyrille Maugeais

5

1 reference

24 December 2017

David Usher

6

1 reference

24 December 2017

Daniel J Rader

7

1 reference

24 December 2017

publication date

8 September 2005

1 reference

24 December 2017

Journal of Lipid Research

published in

1 reference

24 December 2017

volume

46

1 reference

24 December 2017

issue

12

1 reference

24 December 2017

page(s)

2681-2691

1 reference

24 December 2017

The role of lipoprotein(a) in the pathogenesis of atherosclerotic cardiovascular disease and its utility as predictor of coronary heart disease events

cites work

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M500249-JLR200

Lipoprotein(a): intrigues and insights

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M500249-JLR200

The inverse association of plasma lipoprotein(a) concentrations with apolipoprotein(a) isoform size is not due to differences in Lp(a) catabolism but to differences in production rate

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M500249-JLR200

Variation in lipoprotein(a) concentrations among individuals with the same apolipoprotein (a) isoform is determined by the rate of lipoprotein(a) production

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M500249-JLR200

Apolipoprotein(a) gene accounts for greater than 90% of the variation in plasma lipoprotein(a) concentrations

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M500249-JLR200

Structure-function relationships in apolipoprotein(a): insights into lipoprotein(a) assembly and pathogenicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M500249-JLR200

Decreased urinary apolipoprotein (a) excretion in patients with impaired renal function.

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M500249-JLR200

Apolipoprotein(a) and ischaemic heart disease in familial hypercholesterolaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M500249-JLR200

Studies on the role of specific cell surface receptors in the removal of lipoprotein (a) in man

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M500249-JLR200

Defects in the low density lipoprotein receptor gene affect lipoprotein (a) levels: multiplicative interaction of two gene loci associated with premature atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M500249-JLR200

Identification of megalin/gp330 as a receptor for lipoprotein(a) in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M500249-JLR200

Heterogeneous lipoprotein (a) size isoforms differ by their interaction with the low density lipoprotein receptor and the low density lipoprotein receptor-related protein/alpha 2-macroglobulin receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M500249-JLR200

The atherogenic lipoprotein Lp(a) is internalized and degraded in a process mediated by the VLDL receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M500249-JLR200

The low density lipoprotein receptor is not required for normal catabolism of Lp(a) in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M500249-JLR200

Physiological parameter values for physiologically based pharmacokinetic models

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M500249-JLR200

Galactose-specific asialoglycoprotein receptor is involved in lipoprotein (a) catabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M500249-JLR200

The recurring evolution of lipoprotein(a). Insights from cloning of hedgehog apolipoprotein(a).

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M500249-JLR200

Expression of human apolipoprotein B and assembly of lipoprotein(a) in transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M500249-JLR200

Transgenic mice expressing high plasma concentrations of human apolipoprotein B100 and lipoprotein(a).

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M500249-JLR200

Atherogenesis in transgenic mice with human apolipoprotein B and lipoprotein (a).

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M500249-JLR200

Atherogenesis in transgenic mice expressing human apolipoprotein(a)

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M500249-JLR200

Low density lipoprotein receptor-negative mice expressing human apolipoprotein B-100 develop complex atherosclerotic lesions on a chow diet: no accentuation by apolipoprotein(a).

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M500249-JLR200

Tissue distribution of [3H]cholesteryl linoleyl ether-labeled human Lp(a) in different rat organs

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M500249-JLR200

Apolipoprotein(a) isoform-specific changes of lipoprotein(a) after kidney transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M500249-JLR200

The apolipoprotein(a) size polymorphism is associated with nephrotic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M500249-JLR200

Apolipoprotein(a) kringle 4-containing fragments in human urine. Relationship to plasma levels of lipoprotein(a).

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M500249-JLR200

Kringle-containing fragments of apolipoprotein(a) circulate in human plasma and are excreted into the urine

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M500249-JLR200

Lipoprotein(a) in subjects with familial defective apolipoprotein B100.

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M500249-JLR200

Overexpression of human low density lipoprotein receptors leads to accelerated catabolism of Lp(a) lipoprotein in transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M500249-JLR200

Apolipoprotein E competitively inhibits receptor-dependent low density lipoprotein uptake by the liver but has no effect on cholesterol absorption or synthesis in the mouse

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M500249-JLR200

Mouse very low-density lipoprotein receptor (VLDLR): gene structure, tissue-specific expression and dietary and developmental regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M500249-JLR200

Organ distribution in rats of two members of the low-density lipoprotein receptor gene family, gp330 and LRP/alpha 2MR, and the receptor-associated protein (RAP)

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M500249-JLR200

The asialoglycoprotein receptor: a model for endocytic transport receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M500249-JLR200

An apolipoprotein(a) peptide delays chylomicron remnant clearance and increases plasma remnant lipoproteins and atherosclerosis in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M500249-JLR200

10.1194/JLR.M500249-JLR200

21 January 2018

Identifiers

DOI

1 reference

24 December 2017

1 reference

24 December 2017